CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan · Delayed Price · Currency is TWD 93.80
+1.20 (1.30%)
Dec 3, 2025, 1:35 PM CST
CH Biotech R&D Market Cap
CH Biotech R&D has a market cap or net worth of 9.64 billion as of December 3, 2025. Its market cap has increased by 14.11% in one year.
Market Cap
9.64B
Enterprise Value
10.09B
Revenue
1.77B
Ranking
n/a
PE Ratio
22.08
Stock Price
93.80
Market Cap Chart
Since July 2, 2015, CH Biotech R&D's market cap has increased from 7.47B to 9.64B, an increase of 29.08%. That is a compound annual growth rate of 2.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 9.52B | 14.60% |
| Dec 31, 2024 | 8.31B | 0.37% |
| Dec 29, 2023 | 8.28B | 13.05% |
| Dec 30, 2022 | 7.32B | 42.15% |
| Dec 30, 2021 | 5.15B | 20.79% |
| Dec 31, 2020 | 4.26B | -25.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nan Ya Plastics | 467.92B |
| China Steel | 278.30B |
| Formosa Plastics | 265.13B |
| Formosa Chemicals & Fibre | 195.36B |
| TCC Group Holdings | 171.22B |
| Asia Cement | 137.61B |
| Walsin Lihwa | 130.72B |
| Taiwan Glass Ind. | 103.96B |